<SEC-DOCUMENT>0001193125-23-159832.txt : 20230602
<SEC-HEADER>0001193125-23-159832.hdr.sgml : 20230602
<ACCEPTANCE-DATETIME>20230602160958
ACCESSION NUMBER:		0001193125-23-159832
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20230602
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230602
DATE AS OF CHANGE:		20230602

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		23988763

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d515611d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20230602" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-06-02_to_2023-06-02">CVS HEALTH Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-06-02_to_2023-06-02">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-06-02_to_2023-06-02">0000064803</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cvs-20230602.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-06-02_to_2023-06-02"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-02</xbrli:startDate> <xbrli:endDate>2023-06-02</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-06-02_to_2023-06-02">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-06-02_to_2023-06-02" format="ixt:datemonthdayyearen">June 2, 2023</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img src="g515611g89v88.jpg" alt="LOGO" /></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">CVS HEALTH CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-06-02_to_2023-06-02" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-06-02_to_2023-06-02">001-01011</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-06-02_to_2023-06-02">05-0494040</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction<br />of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-06-02_to_2023-06-02">One CVS Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-06-02_to_2023-06-02">Woonsocket</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-06-02_to_2023-06-02" format="ixt-sec:stateprovnameen">Rhode Island</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-06-02_to_2023-06-02">02895</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-06-02_to_2023-06-02">(401)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-06-02_to_2023-06-02">765-1500</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Former name or former address, if changed since last report: N/A</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-06-02_to_2023-06-02" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-06-02_to_2023-06-02" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-06-02_to_2023-06-02" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-06-02_to_2023-06-02" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-06-02_to_2023-06-02">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-06-02_to_2023-06-02">CVS</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-06-02_to_2023-06-02" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-06-02_to_2023-06-02" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Section&#160;8 - Other Events </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;8.01 Other Events. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;2, 2023, CVS Health Corporation, a Delaware corporation (the &#8220;Company&#8221;), issued and sold $1,000,000,000 aggregate principal amount of the Company&#8217;s 5.000% Senior Notes due 2029 (the &#8220;2029 Notes&#8221;), $750,000,000 aggregate principal amount of the Company&#8217;s 5.250% Senior Notes due 2031 (the &#8220;2031 Notes&#8221;), $1,250,000,000 aggregate principal amount of the Company&#8217;s 5.300% Senior Notes due 2033 (the &#8220;2033 Notes&#8221;), $1,250,000,000 aggregate principal amount of the Company&#8217;s 5.875% Senior Notes due 2053 (the &#8220;2053 Notes&#8221;) and $750,000,000 aggregate principal amount of the Company&#8217;s 6.000% Senior Notes due 2063 (the &#8220;2063 Notes&#8221; and, together with the 2029 Notes, the 2031 Notes, 2033 Notes and the 2053 Notes, the &#8220;Notes&#8221;). The Notes were offered pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3ASR,</span> File <span style="white-space:nowrap">No.&#160;333-272200,</span> dated May&#160;25, 2023 (the &#8220;Registration Statement&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes are governed by and issued pursuant to a Senior Indenture dated August&#160;15, 2006 between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the &#8220;Senior Indenture&#8221;). The Company may issue additional senior debt securities from time to time pursuant to the Senior Indenture. The form of Senior Indenture was filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed on August&#160;15, 2006 and shall be incorporated by reference into this Current Report on Form <span style="white-space:nowrap">8-K.</span> The forms of the Notes are filed as Exhibits 4.1, 4.2, 4.3, 4.4 and 4.5 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and are incorporated by reference into the Registration Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Section&#160;9&#160;&#8211;&#160;Financial Statements and Exhibits </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;9.01 Financial Statements and Exhibits. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)<span style="text-decoration:underline"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="text-decoration:underline">Exhibits</span>. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exhibits to this Current Report on Form <span style="white-space:nowrap">8-K</span> are as follows: </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INDEX TO EXHIBITS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d515611dex41.htm">Form of the 2029 Note. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d515611dex42.htm">Form of the 2031 Note. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d515611dex43.htm">Form of the 2033 Note. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d515611dex44.htm">Form of the 2053 Note. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d515611dex45.htm">Form of the 2063 Note. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d515611dex51.htm">Opinion of Shearman&#160;&amp; Sterling LLP. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d515611dex51.htm">Consent of Shearman&#160;&amp; Sterling LLP (included in Exhibit&#160;5.1). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">CVS HEALTH CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: June&#160;2, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">/s/ Shawn M. Guertin</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Shawn M. Guertin</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President and Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d515611dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 DW7 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650DW70 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.000% Senior Note due 2029 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on January&nbsp;30, 2029. If such maturity date is not a Business Day, then payment
of principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: January&nbsp;30 and July 30. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each January&nbsp;15 and July&nbsp;15, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>CVS HEALTH CORPORATION</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Note No.&nbsp;[&nbsp;&nbsp;&nbsp;&nbsp;] of 2029 Notes</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: June&nbsp;2, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Note No.&nbsp;[&nbsp;&nbsp;&nbsp;&nbsp;] of 2029 Notes</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.000&nbsp;% Senior Note due 2029 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 5.000% Senior Notes due 2029 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interest </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on January&nbsp;30 and July&nbsp;30 of each year, commencing January&nbsp;30, 2024.
Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from June 2, 2023. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Method of Payment </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of business on the January&nbsp;15 and July&nbsp;15 (whether or not a Business Day) immediately preceding the interest
payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest
in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the
Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered address. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Paying Agent and Registrar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Indenture </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$1,000,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time,
at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes
to be redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at
a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Par Call Date</B>&#148; means December&nbsp;30, 2028 (one month prior to the maturity date of the Notes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Spread</B>&#148; means 20 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance with the
following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as
yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily)&#151;H.15&#148; (or any successor designation or
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
publication) (&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15
TCM&#148;). In determining the Treasury Rate, the Company shall select, as applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the
&#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and
one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields
and rounding the result to three decimal places; or (3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the
redemption date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate
the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or
with a maturity that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date
equally distant from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding the Applicable Par Call Date. If there are two or
more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States
Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate
in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00
a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company&#146;s actions and
determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notice of any
redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of DTC. No
Notes of a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed. A new
Note in a principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary), the
redemption of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unless the Company defaults in payment of the redemption price, on and after the redemption
date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Repurchase of the Notes Upon a Change of
Control Triggering Event </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to
require the Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in
this Note. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but
excluding, the date of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or
transactions that constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed
(the &#147;<B>Change of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the
Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the
provisions of any securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its
obligations under the Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of
Control Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not be required to make a Change of Control Offer upon the occurrence of a
Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and the third party repurchases all Notes properly tendered and
not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of default under the Indenture, other than a default in the payment of the
Change of Control Payment upon a Change of Control Triggering Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are
applicable: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by
each of the Rating Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public
notice of the occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating
Agencies); <I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will
not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or
publicly confirm or inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the
applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of any report under
or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of the
Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change
of Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or
higher than Baa3 (or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Denominations; Transfer; Exchange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Persons Deemed Owners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Unclaimed Money </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates
another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying Agent for payment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Discharge and Defeasance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Amendment; Waiver </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject
to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance
with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the
Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture
or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Defaults and Remedies
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes
may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse to enforce the
Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power. The Trustee may
withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Trustee Dealings with the Company </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) No Recourse Against Others </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Abbreviations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Governing Law </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) CUSIP Numbers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Your
Signature:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>d515611dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 DX5 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650DX53 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.250% Senior Note due 2031 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on January&nbsp;30, 2031. If such maturity date is not a Business Day, then payment
of principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: January&nbsp;30 and July 30. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each January&nbsp;15 and July&nbsp;15, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Note No.&nbsp;[&nbsp;&nbsp;&nbsp;&nbsp;] of 2031 Notes</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: June&nbsp;2, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Note No.&nbsp;[&nbsp;&nbsp;&nbsp;&nbsp;] of 2031 Notes</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.250% Senior Note due 2031 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 5.250% Senior Notes due 2031 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interest </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on January&nbsp;30 and July&nbsp;30 of each year, commencing January&nbsp;30, 2024.
Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from June 2, 2023. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) Method of Payment </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of business on the January&nbsp;15 and July&nbsp;15 (whether or not a Business Day) immediately preceding the interest
payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest
in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the
Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered address. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Paying Agent and Registrar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Indenture </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$750,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time,
at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes
to be redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at
a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Par Call Date</B>&#148; means November&nbsp;30, 2030 (two months prior to the maturity date of the Notes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Spread</B>&#148; means 25 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance with the
following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as
yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily)&#151;H.15&#148; (or any successor designation or
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
publication) (&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15
TCM&#148;). In determining the Treasury Rate, the Company shall select, as applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the
&#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and
one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields
and rounding the result to three decimal places; or (3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the
redemption date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate
the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or
with a maturity that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date
equally distant from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding the Applicable Par Call Date. If there are two or
more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States
Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate
in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00
a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company&#146;s actions and
determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notice of any
redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of DTC. No
Notes of a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed. A new
Note in a principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary), the
redemption of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unless the Company defaults in payment of the redemption price, on and after the redemption
date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Repurchase of the Notes Upon a Change of
Control Triggering Event </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to
require the Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in
this Note. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but
excluding, the date of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or
transactions that constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed
(the &#147;<B>Change of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the
Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the
provisions of any securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its
obligations under the Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of
Control Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not be required to make a Change of Control Offer upon the occurrence of a
Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and the third party repurchases all Notes properly tendered and
not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of default under the Indenture, other than a default in the payment of the
Change of Control Payment upon a Change of Control Triggering Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are
applicable: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each
of the Rating Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of
the occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating
Agencies); <I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will
not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or
publicly confirm or inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the
applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of any report under
or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of the
Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change
of Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or
higher than Baa3 (or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Denominations; Transfer; Exchange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Persons Deemed Owners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Unclaimed Money </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates
another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying Agent for payment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Discharge and Defeasance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Amendment; Waiver </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject
to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance
with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the
Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture
or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Defaults and Remedies
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes
may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse to enforce the
Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power. The Trustee may
withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Trustee Dealings with the Company </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) No Recourse Against Others </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Abbreviations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Governing Law </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) CUSIP Numbers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Your Signature:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>d515611dex43.htm
<DESCRIPTION>EX-4.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No.&nbsp;[&#149;]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">$[&#149;]</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 DY3 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650DY37 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.300% Senior Note due 2033 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on June&nbsp;1, 2033. If such maturity date is not a Business Day, then payment of
principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: June&nbsp;1 and December 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each May&nbsp;15 and November&nbsp;15, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Signature Page
to Note No.&nbsp;[&nbsp;&nbsp;&nbsp;&nbsp;] of 2033 Notes</I>]<I> </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: June&nbsp;2, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Authorized Signatory</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Signature Page
to Note No. [&nbsp;&nbsp;&nbsp;&nbsp;] of 2033 Notes</I>]<I> </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.300% Senior Note due 2033 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 5.300% Senior Notes due 2033 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Interest </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on June&nbsp;1 and December&nbsp;1 of each year, commencing December&nbsp;1, 2023.
Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from June 2, 2023. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Method of Payment </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of
business on the May&nbsp;15 and November&nbsp;15 (whether or not a Business Day) immediately preceding the interest payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender
Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer
of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered
address. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Paying Agent and Registrar </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indenture </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$1,250,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Optional Redemption </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time,
at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes
to be redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at
a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Par Call Date</B>&#148; means March&nbsp;1, 2033 (three months prior to the maturity date of the Notes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Spread</B>&#148; means 25 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance with the
following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as
yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily)&#151;H.15&#148; (or any successor designation or
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
publication) (&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15
TCM&#148;). In determining the Treasury Rate, the Company shall select, as applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the
&#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and
one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields
and rounding the result to three decimal places; or (3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the
redemption date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate
the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or
with a maturity that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date
equally distant from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding the Applicable Par Call Date. If there are two or
more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States
Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate
in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00
a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company&#146;s actions and
determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notice of any
redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of DTC. No
Notes of a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed. A new
Note in a principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary), the
redemption of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unless the Company defaults in payment of the redemption price, on and after the redemption
date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Repurchase of the Notes Upon a Change of Control Triggering Event </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to require the Company to
repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in this Note. In the Change
of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but excluding, the date of purchase
(the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or transactions that constitute the
Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (the &#147;<B>Change of Control
Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act and any other
securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any
securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the
Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of Control Payment Date, the
Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not be required to make a Change of Control Offer upon the occurrence of a
Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and the third party repurchases all Notes properly tendered and
not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of default under the Indenture, other than a default in the payment of the
Change of Control Payment upon a Change of Control Triggering Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are
applicable: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each
of the Rating Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of
the occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating
Agencies); <I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will
not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or
publicly confirm or inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the
applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of any report under
or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of the
Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change
of Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or
higher than Baa3 (or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Denominations; Transfer; Exchange </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Persons Deemed Owners </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unclaimed Money </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee
or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying
Agent for payment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Discharge and Defeasance </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amendment; Waiver </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the
Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then
outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does
not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Defaults and Remedies </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes may
declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse to enforce the
Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power. The Trustee may
withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of Notes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Trustee Dealings with the Company </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No Recourse Against Others </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authentication </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Abbreviations </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Governing Law </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall be governed by, and construed in accordance with, the laws of the State of New York. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">CUSIP Numbers </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Your&nbsp;Signature:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>5
<FILENAME>d515611dex44.htm
<DESCRIPTION>EX-4.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 DZ0 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650DZ02 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.875% Senior Note due 2053 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on June&nbsp;1, 2053. If such maturity date is not a Business Day, then payment of
principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: June&nbsp;1 and December 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each May&nbsp;15 and November&nbsp;15, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>CVS HEALTH CORPORATION</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Signature Page to Note No. [&nbsp;&nbsp;&nbsp;&nbsp;] of 2053 Notes</I>]<I> </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: June&nbsp;2, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Authorized Signatory</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [&nbsp;&nbsp;&nbsp;&nbsp;] of 2053 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.875% Senior Note due 2053 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 5.875% Senior Notes due 2053 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interest </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on June&nbsp;1 and December&nbsp;1 of each year, commencing December&nbsp;1, 2023.
Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from June 2, 2023. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Method of Payment </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of business on the May&nbsp;15 and November&nbsp;15 (whether or not a Business Day) immediately preceding the interest
payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest
in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the
Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered address. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Paying Agent and Registrar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Indenture </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$1,250,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time,
at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes
to be redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at
a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Par Call Date</B>&#148; means December&nbsp;1, 2052 (six months prior to the maturity date of the Notes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Spread</B>&#148; means 30 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance with the
following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as
yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily)&#151;H.15&#148; (or any successor designation or
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
publication) (&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15
TCM&#148;). In determining the Treasury Rate, the Company shall select, as applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the
&#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and
one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields
and rounding the result to three decimal places; or (3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the
redemption date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate
the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or
with a maturity that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date
equally distant from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding the Applicable Par Call Date. If there are two or
more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States
Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate
in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00
a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company&#146;s actions and
determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notice of any
redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of DTC. No
Notes of a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed. A new
Note in a principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary), the
redemption of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unless the Company defaults in payment of the redemption price, on and after the redemption
date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Repurchase of the Notes Upon a Change of
Control Triggering Event </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to
require the Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in
this Note. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but
excluding, the date of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or
transactions that constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed
(the &#147;<B>Change of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the
Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the
provisions of any securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its
obligations under the Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of
Control Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not be required to make a Change of Control Offer upon the occurrence of a
Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and the third party repurchases all Notes properly tendered and
not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of default under the Indenture, other than a default in the payment of the
Change of Control Payment upon a Change of Control Triggering Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are
applicable: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each
of the Rating Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of
the occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating
Agencies); <I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will
not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or
publicly confirm or inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the
applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of any report under
or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of the
Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change of
Control and a Below Investment Grade Rating Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any member of
the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a majority of the
Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee for election as a
director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3
(or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Denominations; Transfer; Exchange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Persons Deemed Owners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Unclaimed Money </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates
another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying Agent for payment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Discharge and Defeasance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Amendment; Waiver </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject
to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance
with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the
Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture
or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Defaults and Remedies
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes
may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse to enforce the
Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power. The Trustee may
withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Trustee Dealings with the Company </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) No Recourse Against Others </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Abbreviations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Governing Law </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) CUSIP Numbers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The agent may substitute another to act for him. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Your&nbsp;Signature:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>6
<FILENAME>d515611dex45.htm
<DESCRIPTION>EX-4.5
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 EA4 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650EA42 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6.000% Senior Note due 2063 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on June&nbsp;1, 2063. If such maturity date is not a Business Day, then payment of
principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: June&nbsp;1 and December 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each May&nbsp;15 and November&nbsp;15, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Signature Page to Note No. [&nbsp;&nbsp;&nbsp;&nbsp;] of 2063 Notes</I>]<I> </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: June&nbsp;2, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Signature Page to Note No. [&nbsp;&nbsp;&nbsp;&nbsp;] of 2063 Notes</I>]<I> </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6.000% Senior Note due 2063 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 6.000% Senior Notes due 2063 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interest </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on June&nbsp;1 and December&nbsp;1 of each year, commencing December&nbsp;1, 2023.
Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from June 2, 2023. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Method of Payment </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of business on the May&nbsp;15 and November&nbsp;15 (whether or not a Business Day) immediately preceding the interest
payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest
in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the
Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered address. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Paying Agent and Registrar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Indenture </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$750,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time,
at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes
to be redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at
a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Par Call Date</B>&#148; means December&nbsp;1, 2062 (six months prior to the maturity date of the Notes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Spread</B>&#148; means 35 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance with the
following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as
yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily) - H.15&#148; (or any successor designation or
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
publication) (&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15
TCM&#148;). In determining the Treasury Rate, the Company shall select, as applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the
&#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and
one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields
and rounding the result to three decimal places; or (3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the
redemption date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate
the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or
with a maturity that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date
equally distant from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding the Applicable Par Call Date. If there are two or
more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States
Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate
in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00
a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company&#146;s actions and
determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notice of any
redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of DTC. No
Notes of a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed. A new
Note in a principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary), the
redemption of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unless the Company defaults in payment of the redemption price, on and after the redemption
date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Repurchase of the Notes Upon a Change of
Control Triggering Event </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to
require the Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in
this Note. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but
excluding, the date of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or
transactions that constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed
(the &#147;<B>Change of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the
Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the
provisions of any securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its
obligations under the Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of
Control Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not be required to make a Change of Control Offer upon the occurrence of a
Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and the third party repurchases all Notes properly tendered and
not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of default under the Indenture, other than a default in the payment of the
Change of Control Payment upon a Change of Control Triggering Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are
applicable: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each
of the Rating Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of
the occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating
Agencies); <I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will
not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or
publicly confirm or inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the
applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of any report under
or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of the
Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change
of Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or
higher than Baa3 (or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Denominations; Transfer; Exchange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Persons Deemed Owners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Unclaimed Money </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates
another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying Agent for payment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Discharge and Defeasance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Amendment; Waiver </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject
to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance
with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the
Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture
or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Defaults and Remedies
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes
may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse to enforce the
Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power. The Trustee may
withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Trustee Dealings with the Company </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) No Recourse Against Others </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Abbreviations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Governing Law </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) CUSIP Numbers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The agent may substitute another to act for him. </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your&nbsp;Signature:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>7
<FILENAME>d515611dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g515611g0601223404883.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">599 LEXINGTON AVENUE </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NEW YORK, NY 10022-6069 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">+1.212.848.4000 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">June&nbsp;2, 2023
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One CVS Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Woonsocket, RI 02895 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$1,000,000,000 5.000% Senior Notes due 2029 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$750,000,000 5.250% Senior Notes due 2031 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$1,250,000,000 5.300% Senior Notes due 2033 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$1,250,000,000 5.875% Senior Notes due 2053 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$750,000,000 6.000% Senior Notes due 2063 </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as counsel to CVS Health
Corporation, a Delaware corporation (the &#147;Company&#148;), in connection with the issuance and sale by the Company of $1,000,000,000 aggregate principal amount of the Company&#146;s 5.000% Senior Notes due 2029 (the &#147;2029 Notes&#148;),
$750,000,000 aggregate principal amount of the Company&#146;s 5.250% Senior Notes due 2031 (the &#147;2031 Notes&#148;), $1,250,000,000 aggregate principal amount of the Company&#146;s 5.300% Senior Notes due 2033 (the &#147;2033 Notes&#148;),
$1,250,000,000 aggregate principal amount of the Company&#146;s 5.875% Senior Notes due 2053 (the &#147;2053 Notes&#148;), and $750,000,000 aggregate principal amount of the Company&#146;s 6.000% Senior Notes due 2063 (the &#147;2063 Notes&#148;
and, together with the 2029 Notes, the 2031 Notes, the 2033 Notes and the 2053 Notes, the &#147;Notes&#148;), pursuant to the Underwriting Agreement, dated May&nbsp;30, 2023 (the &#147;Underwriting Agreement&#148;), among the Company and the
underwriters named therein. The Notes will be issued pursuant to an indenture, dated as of August&nbsp;15, 2006 (the &#147;Indenture&#148;), between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the
&#147;Trustee&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In that connection, we have reviewed originals or copies of the following documents: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Underwriting Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Executive Officers&#146; Certificate pursuant to the Indenture dated June&nbsp;2, 2023; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Notes in global form as executed by the Company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SHEARMAN.COM </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shearman&nbsp;&amp; Sterling LLP is a limited liability partnership organized in the United States under the laws of the state of Delaware, which laws limit
the personal liability of partners. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The documents described in the foregoing clauses (a)&nbsp;through (d) are collectively referred to herein as
the &#147;Opinion Documents&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In our review of the Opinion Documents, we have assumed: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The genuineness of all signatures. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The authenticity of the originals of the documents submitted to us. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The conformity to authentic originals of any documents submitted to us as copies. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As to matters of fact, the truthfulness of the representations made in the Underwriting Agreement and the other
Opinion Documents and in certificates of public officials and officers of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That each of the Opinion Documents is the legal, valid and binding obligation of each party thereto, other than
the Company, enforceable against each such party in accordance with its terms. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That the execution, delivery and performance by the Company of the Opinion Documents to which it is a party do
not and will not, except with respect to Generally Applicable Law, violate any law, rule or regulation applicable to it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That the execution, delivery and performance by the Company of the Opinion Documents to which it is a party do
not and will not result in any conflict with or breach of any agreement or document binding on it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That, except with respect to Generally Applicable Law, no authorization, approval, consent or other action by,
and no notice to or filing with, any governmental authority or regulatory body or any other third party is required for the due execution, delivery or performance by the Company of any Opinion Document to which it is a party or, if any such
authorization, approval, consent, action, notice or filing is required, it has been duly obtained, taken, given or made and is in full force and effect. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not independently established the validity of the foregoing assumptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Generally Applicable Law&#148; means the federal law of the United States of America, and the law of the State of New&nbsp;York (including in each case
the rules or regulations promulgated thereunder or pursuant thereto), that a New&nbsp;York lawyer exercising customary professional diligence would reasonably be expected to recognize as being applicable to the Company, the Opinion Documents or the
transactions governed by the Opinion Documents, and for purposes of assumption paragraphs (f)&nbsp;and (h) above and our opinion below, the General Corporation Law of the State of Delaware. Without limiting the generality of the foregoing definition
of Generally Applicable Law, the term &#147;Generally Applicable Law&#148; does not include any law, rule or regulation that is applicable to the Company, the Opinion Documents or such transactions solely because such law, rule or regulation is part
of a regulatory regime applicable to any party to any of the Opinion Documents or any of its affiliates due to the specific assets or business of such party or such affiliate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon the foregoing and upon such other investigation as we have deemed necessary and subject to the qualifications set forth below, we are of the
opinion that the Notes have been duly authorized and executed by the Company and, when authenticated by the Trustee in accordance with the Indenture and delivered and paid for as provided in the Underwriting Agreement, the Notes will be the legal,
valid and binding obligations of the Company, enforceable against the Company in accordance with their terms and entitled to the benefits of the Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion expressed above is subject to the following qualifications: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinion above is subject to the effect of any applicable bankruptcy, insolvency, reorganization, moratorium
or similar laws affecting creditors&#146; rights generally (including without limitation all laws relating to fraudulent transfers). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinion above is also subject to the effect of general principles of equity, including without limitation
concepts of materiality, reasonableness, good faith and fair dealing (regardless of whether considered in a proceeding in equity or at law). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinion is limited to Generally Applicable Law, and we do not express any opinion herein concerning any
other law. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion letter speaks only as of the date hereof. We expressly disclaim any responsibility to advise you of any
development or circumstance of any kind, including any change of law or fact, that may occur after the date of this opinion letter and which might affect the opinions expressed herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion letter is rendered to you in connection with the transactions contemplated by the Opinion Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as an exhibit to the Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> to be filed
June&nbsp;2, 2023 by the Company and incorporated by reference into the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3ASR</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-272200)</FONT> filed by the Company to effect
the registration of the Notes under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and to the use of our name under the heading &#147;Legal Matters&#148; in the prospectus constituting a part of such Registration Statement.
In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Securities and Exchange Commission promulgated thereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Shearman&nbsp;&amp; Sterling LLP
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LN/eb/ss/dh </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RA </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>cvs-20230602.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 6/3/2023 12:02:12 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:cvs="http://www.cvshealth.com/20230602"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.cvshealth.com/20230602"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20230602_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20230602_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cvs-20230602_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 6/3/2023 12:02:12 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cvs-20230602_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 6/3/2023 12:02:12 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cvs-20230602.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g515611g0601223404883.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g515611g0601223404883.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  , /<# 2(  A$! Q$!_\0
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M9YW[><GUJMJ7A^RO[WQJ)S*?M4,+-A@-K(I*E>."#6MJ<7]I_"^2*ZD=_.L
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MNJ3%KZPU*)HWR?WT#1DHWOCI^%=IXQ6+7/'MEX?U/SGT:'3I+^:WC8@7#!L
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38> ]*M8BQCCC8 L<G[[44 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g515611g89v88.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g515611g89v88.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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7-E<K_P (A#>X+,"NM+%]^U=G-@V/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139704152457792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 02, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  02,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>d515611d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20230602.xsd" xlink:type="simple"/>
    <context id="duration_2023-06-02_to_2023-06-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2023-06-02</startDate>
            <endDate>2023-06-02</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-06-02_to_2023-06-02"
      id="Hidden_dei_EntityRegistrantName">CVS HEALTH Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-06-02_to_2023-06-02">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-06-02_to_2023-06-02"
      id="Hidden_dei_EntityCentralIndexKey">0000064803</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-06-02_to_2023-06-02">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-06-02_to_2023-06-02">2023-06-02</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-06-02_to_2023-06-02">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-06-02_to_2023-06-02">001-01011</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-06-02_to_2023-06-02">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-06-02_to_2023-06-02">One CVS Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-06-02_to_2023-06-02">Woonsocket</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-06-02_to_2023-06-02">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-06-02_to_2023-06-02">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-06-02_to_2023-06-02">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-06-02_to_2023-06-02">765-1500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-06-02_to_2023-06-02">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-06-02_to_2023-06-02">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-06-02_to_2023-06-02">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-06-02_to_2023-06-02">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-06-02_to_2023-06-02">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-06-02_to_2023-06-02">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-06-02_to_2023-06-02">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-06-02_to_2023-06-02">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MP %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ .X'"5I>*NQS     $P(
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MB^$_7G\!4$L! A0#%     @ .X'"5@=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  [@<)6%@8[;>\
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M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( #N!PE:7BKL<P    !,"   +
M      "  5\/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( #N!PE8<.&7J/P$
M #P"   /              "  4@0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    "  [@<)6)!Z;HJT   #X 0  &@              @ &T$0  >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  [@<)699!YDAD!  #/
M P  $P              @ &9$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    "0 ) #X"  #C$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d515611d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d515611d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d515611d8k.htm">d515611d8k.htm</File>
    <File>cvs-20230602.xsd</File>
    <File>cvs-20230602_lab.xml</File>
    <File>cvs-20230602_pre.xml</File>
    <File>d515611dex41.htm</File>
    <File>d515611dex42.htm</File>
    <File>d515611dex43.htm</File>
    <File>d515611dex44.htm</File>
    <File>d515611dex45.htm</File>
    <File>d515611dex51.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g515611g89v88.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d515611d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d515611d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20230602_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20230602_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20230602.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20230602",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d515611d8k.htm",
      "contextRef": "duration_2023-06-02_to_2023-06-02",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d515611d8k.htm",
      "contextRef": "duration_2023-06-02_to_2023-06-02",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com//20230602/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001193125-23-159832-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-159832-xbrl.zip
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M5O42HMA5TW[=D#P7,8^WG]F<FT(B_N0O65TR[;D= 5II!,MC7' MUR.B-BT
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M]L)87@C22I"5(GJ-KT4;EA?YZGHIGKC21^;O3F2G>/K7%_29_P!02P,$%
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M"VE;==_(\HJE@&\!+R^>6'M/F%<6W<=Q>2>K:8T[,RO.J3YSPU]<)NISV95
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MI8?%$R&(_'T9KKU7^UM8Y4 "D4STVKH"@)I;X,$;LT#]1=,+YG,X6G@%5KU
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M;9X<O3CI=S[#EV>CB_/C_P]02P,$%     @ .X'"5J]*%]6$*   8+\  !
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MNQ^ZQ^UAQX./E_W.H',Q[)QX1Y^]]H77OAJ>]OK=_X8O^AWU8WO8_:WC]3[
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MG"=!Y =S$<+.9EX\\0R]> "(OXHH%\F2!WRYVZ3C:WG=B4<0F@G8:) MO;&
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MI1MH< #U-2I"%&>I<_Q&A,></U-P#>EP&/>4B9RPKEL8J[UB>3C6SHB@'IU
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M&7(\^E6_)>"_+7@<@?Y'X_PJ^_5S&WX]^:+71-MH]?IP'+"2S[UNY]/'JW.
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M0L@=C, =1L)']%))R@-(SXL7]GTYBQ8P44+0D,- $=!HFRKVHY$8 \"JE@^
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M@:PL2G<LSC.DYQ2A1TT1&F]@BE!/@1[C3;7PRG#D:DZ^S%.N=("?3F'0. I
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M!YJDZ>Z X*F\@4>;I1R;U\H!%3N-.&?/A&)H1C]_#F8]^GFN>7C4NT#>>\;
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M9N@]LYIG5O-,+<^LYH>P&N?Y8TOG$?UA8).AI86V61_L$TDNH@LTS,  ($,
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M8,0-4EY(,?>0CI0X *&CC\8MIG8!X2BQR:?]>RSH9O:&%B\/C!HR"@(D+,P
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MGF"+K>&3MIS2ZUQ!5H-:'Z-DB UBZ,!0@(,^RME=N*/24S\-3=8F=7&LG(P
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M_0-,4HJ^RVU%]I(_S3CS35"7^VGI'!Z.YV'0FHAC902DPKG5NCQ/58]'L]H
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M+MWT!O;5& X#)'E 42"OFR"%OU,DC&P"&$%\#-E%*C-$KFRB<2^1-S))X8<
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M:*SFM>N->NW9XQV@>?>3>9I)6?-\F63!*$"_R41DK(K#_^)(&6X2+.M!YO5
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M]P_1Y;Q&:S3J&H@T8#/K=D_G6=Q^:4*!V9&2D4NU&'1?1#527D@K=Y".-#@
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M'X+XOV&9,0A8$2]&;P$R PK/P() ;06"D$D2)\\/BS8E3%&:=K3,*9(V*SG
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M[._.(;"E*3FZ=(:HZ?2"[:U"?H'V-)F3O@N\JL(JER/\&00![/BU4KVL^8[
MNAN/[P8N%XAH[0"^6$GT55BBU7#2-(5O GK.9U640T[3()LKW>$>U$:>'CQE
M%2QPR,-AADZJM2VTT0H K;^FBC+I&;W;"'72) RT<US#4A7TA<)XT;6":WQ;
M/!<:70H^5(R'JOGVUCU/LY#' 4I!D18=J6X.A@*XII W&CJDJNM\RJHNJ&P+
M:T+#I54AU* FW:P[#^]1W+G_1N[NZ[PK$UW<WFI^4Q4EF#)/H@[+/$CU<9P
MH5@P@($:YZ%P))@:BK<.G)S*R"@9O/0=5+4<FQV)/XXBI:$[6RP71&1[JUA,
M?#_.#P MK(V3SK!CK-N$DQP[A0US=UNS=ECI"!:>V76N3E_L[&G2K>ZBV^(I
M.T"ZZQSP,PV)YMUJ4 45/\Q3Y+Q@-U_<!IGOO1'$Y)L@R>;2^"\T6'@AM(_
M*KVPXN=79CH%"645%I>*;S^46@&I82.C>8C?'J[OD_/NT6URGK;1N]-(I]AO
MI]B/Q]7N=<L6L@.\#]ZZIBT[A1XX;W\I:[2B?GP-5D.NGXSZFZT![@E=\MI^
MX;62"=R!\L_BX>1^U;UP\H?CK7?(W[<?#2@;6*'L5J2B!JC4M"2>R03(FNM6
M44$I"(LU2M01H9CM0J-[T)1W;GW!NO]O6*=\?U9<%,I)2STQZW4:$,,ZY1%%
MH<%?U >-P6H4R!6LYJ2-<HQ]89,O"$L(2WYNCSQU\]0TIS;N;[>04[IF@L$V
MYK3TJ*K&XKADA"P35.<D93\X"'MNP^>3MH^)E3H!Z![6I.NB,5]RIKJQ$>OK
MN?.+M^Y)VPDIC39OX'Z5I9H_"4X;UB/WCJFH$X 5=]NMZ!Q0R3?HNUG29*EJ
M\1 IQX7.WA5@MR0UMV4%:\ VB$/635X=7C'@**BEAZ;P0TG%G<T)XF59^RB]
M5=N@2!S"$.<>)F(1*9V?:K=P2O+FZ#+#$H487W:=6RI"D7HFRPV['BE8L\LE
M($L)B&[N1.YOMZ<1 O)&.6*5?[:L-K.F+%/.4#1/JA/).W/+#ES/.2\X-&^Q
M'I_;=%E-O:.N0W(<&T>4=1J11S,PEO7VEIM0NW[E[WYH@<4)^1Y;T8U,,X+V
MIP31NLM\F,"Z4A^BK7*W%IW2UMF12<T,RL<#:D'S%@Q;AI7Z&A4ABK.4.7XC
MPF/.G\FYAG0XC/O)1$Y8URV*U5ZQ>3C4SHB@')U L@0A&Y'D$:,_[W35Y$OO
M=!*S.?3BZCA_+\_NRDFNPMZTQRW A+?('L9<A$(L+1&F-- <9*"=#+QHE.)1
M! +7ET,N)\2R!?+]D $5IVF 'H]AO(C&B6*&JN^(/=SM+7VZ5;"36L>ZS1JV
MMZSA%Y-X@7>F\&>NRO#N@94.YQ9)D"KLLMX.%6#&K$F*U<S9:X7*,X]RBQ/&
M<,B"JNT.67)@S/SG'(]@5F['OM^F1B4,Q?(-FNU.-EC53:J*U 7RT4GG6 &(
MZ:I'SD]GU@41CP/O&3J_AC&WU5(HPN:'1AQT,P7)E,L585/3G+Z(U8SH(T-T
MS%PQIG,C3"D!/6^;)/U[SJ6%NEN=V<5"HS51^)IZ2>4X5+(+=-L@\>=3S*CT
MN9D?X)$DRD<QKY J[\6LJ0$M5J@XL^,!+"7E7"NR@LMP]86\F,ZWV<*_[X%*
M&ZTQ7-E1B0Q94?HLYS#LTRDTL2?'&IG&Y%$0*D;&Q7]H#S ; RECS@JX%UDQ
M/54#[NV_/KM7 Z/]-V?6$U_T!^7<\5@H'L;,B&0$U.-C=@OP1K!U)L$,5ZA*
MC=]BS:U*.LPW5M"8COTS,6DBB[%=&'91C.<9(BJE5L5E0YC>97J,FYB080;L
M-=$$5?Y(^31'ME:&N! HP7[&Z*_^QFX4-=/? ;M^ D(N!3,#I?P!5,CY04VW
M''T0F[T).G#J',&VIFDI@8561,34(I?ZUYB6N)PP,\S'OFK:%5)L,,%?E@*9
M-7 N=2@%CVI)H75Z]5$UTG#:_N2Z=V1@A$3,-9@#80R5=T&G-5,M$%U5I]@=
MJ.IJSJZ6CV"-)*E/Q68>^;(6IHPDY5I'9)#$V3$M^%^QFY(YI8KF8C<:#0%3
MPWA&)T[7'284[R/"5E:#^7$#+ <T%S27#&T4-'"1BYB6B_P@NHG#FW(S%21I
MKM1-'\1 ^C&9D)8N,&]6?5A07[7=F/JJF4-:L@Z!&5*4%^R8C$!IE4;56T-G
MDWS.0XYJ=5RG.*I;RN6FG:,P<2"B>D\Y]((S4-<>)5$+DY=RD.TM7DR^I:8I
MA2_,B7AZHLNO[K?,*%9TD^,AJ[!,L2YWM+1:3C[X2HJ-3A.O4N(>/%7DUC5U
M!N'2/07,Y*,B)IV022Q8Z?/W.9*7'+$?K&.L*,+W4#I@61-#^,17]6 47;^/
MHO7\7@?G?M@5'KS:(T&8B+FVFG/9WC5.@V8Y<'\Q@!U\#6=<D+BS0Q#ZE[Q4
MTJ\/,TF%8P>3)9JOU,71(ZJ#SE3JG<T25G\S(U\WK1NF!^M3A,K'6)2%92*-
M-KI UYDC*==-5-#45::(AK3GKKRB=$$TF75"C<_]RV+^UEEKN?+R;>ET]0NT
MB.<VM'P4!#DQU740M!1)72V<E0@KQ;!/KNXK&E,_.4I3CHL[V<"] $Z[RU):
M7*%UH<U:$U5#$3T)QD9\G CQFK*'R>5CRB&K"/W+.!Y:/1#C97<9"B<G)[O:
M3E@S:(_N8K[:I&'F[FL%9+E-,YP1JWLRN:'TKE;D\RW2N1NP-[F=@H=C94>&
M0U%=!%#2RKFJ,SG2:IBI"E?F:.X%V+IZGC.'4\XRU7GZ)B8U$D&8.N&/,F>;
M];'9MM:4PB3(/$!#S%PA7&(?DI!"_99AH9L=ATOJ/CZ.^!X1MT^)6D,R%O C
M/:Y M> L1[8&J(&I251[71'5RKL#M\.%MGFWM]#H337[+<1!T+K1]VL-F<F!
MP12'<S<3_TXI4]7>%ZJ;XG0-/.HE@6K-T1"&DESG::8UK<I2[0GVUQILM-^4
M6N<*LFK4^A3& ^P.0P>& ARX,V=WX8X*3_TT-%D95[TS:64$"/&^\@P<64?)
M1IHOVS %>8-,IW7R2VIYY\<89U*U;\XV/%L6I!L$KDT.QVYRWWQ5PH#U G4G
MH5<7'R$"VA;W";[!L-&]ETM+40J=@VT7;NX7QWGNPBG]4IF,7.RJC29&*&!,
MHWD2!>F$M0PPU:A_0S0$FM/64F(7.8S].7]+KA"^#H=RZ<4W%48=R4(";2@6
M[!%&33-S.,3:C8!F,E013#XAUJ6<RP!<8-G8IF%!A2HQ=1U%37M7;.592:&4
M=1)32*FD](G\MKEWJKIRP&E7J^,O>-S[;UF8N&5[(E_B5E:;AZ.6ONK<(Y"_
M-^+9JT\F57.3QQFON4-NSLV0]\HE(L;4IX-CAN_V'287!P4'<-5&4Z>GBV6K
MF^"D0=6[COQ0! C92[J$X[F/N&?:2>="&V( Q!Y'5&I-SE,B=*K3X,M"S)4[
MSGT?)GN'&P,S!G-;5@PXZHV.5%L U1S&C1?!+[F4.7NI$2DM-#,U0]:Y<]JU
MEBE7+<>-YEQ>AIZCTGW8#FS458B9YI5J0MR@HC+5?6NB-V@+DN #7BYL<J-X
M5503$,;Q5ZH%75F?:C)?2*<J;M=)5WUQ(CT-B?T+E)4@!5F2C*6ZSVP$FC?)
MW&<G>$MLIELW-M4)5&2C@-&FY2LI$LJ1@PQMRJ$2CG=0SE!I]8#2AE10P^E[
MG@\CZ8IUQWVB\5/="Y1P8\A/MK]=QYGP5DZ0:[6<*^ZB^B-;LFL:4BU_$BV^
M\K7J-6!#0]S4D?=94*+DAM@S=376*,/J#L'>+08LYF15 B><84\_UZM9B4PQ
MY=01@P 8M,\D86?J%.(Z16NFD8$3:0JBD@Q.-YR9\_SE&SP[)< <(=0)>KH=
M%%_4J,PCM>X%'LK#EGW':G.=% IQTKI70K_W/ QM?!!>V]7AKJPJPPIKX8(J
M3;^&)E$EQ_/R;CE77"!?FH /#X+QG @+[[E,R14,H#;!)]5 G,QM"L@,8\GW
M_$T%=>"AZ"IZR8=  BG=T,77LE#H!8MPT_6;X=B06T?5P-2:4%TR^5;#W.R$
MHOF%5U;C.]+K-4_7%:JA(Y SC1WEWH+*LLA^J[$!K3I$ UI5N_,=4Q@;0UUD
M$W7:D4ZS&NE5J1KLU;31%65M'5,X>/L+V;>W9G8;=$4'/5(_*(@)5VKG,'G
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MB@YSTSN8VTL0*AP4!GL<RY/NB*R7^P+?OSKIG'V!+\_[EQ?'_PM02P,$%
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M8O9787+"EI0:KO4%)[3YI#'\Z.,/W+X='!X*#LXCA4/N*M<A8&62:0> /PT
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MAX6WRL1I/@HR$M=5VJ."+M7/)&@%EC99ZVQWB'T8Q(X>*V(112:G1/4O3P1
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M>5Y-KTE;06*<M'+E_'\"4$L! A0#%     @ .X'"5B<E:[P^ P  3 L  !
M             ( !     &-V<RTR,#(S,#8P,BYX<V102P$"% ,4    "  [
M@<)61FQ,4& &  "^0P  %               @ %L P  8W9S+3(P,C,P-C R
M7VQA8BYX;6Q02P$"% ,4    "  [@<)6903RF;4$  !]*@  %
M    @ '^"0  8W9S+3(P,C,P-C R7W!R92YX;6Q02P$"% ,4    "  [@<)6
M2@)WA+L0  !8<P  #@              @ 'E#@  9#4Q-38Q,60X:RYH=&U0
M2P$"% ,4    "  [@<)6:O0]P8,H  !DOP  $               @ ','P
M9#4Q-38Q,61E>#0Q+FAT;5!+ 0(4 Q0    ( #N!PE:O2A?5A"@  &"_   0
M              "  7U(  !D-3$U-C$Q9&5X-#(N:'1M4$L! A0#%     @
M.X'"5NI,R5).*0  :-L  !               ( !+W$  &0U,34V,3%D97@T
M,RYH=&U02P$"% ,4    "  [@<)6!1K5K\ H  !3PP  $
M@ &KF@  9#4Q-38Q,61E>#0T+FAT;5!+ 0(4 Q0    ( #N!PE8?]K2PS"@
M .C%   0              "  9G#  !D-3$U-C$Q9&5X-#4N:'1M4$L! A0#
M%     @ .X'"5EGN_G)N#@  [TP  !               ( !D^P  &0U,34V
M,3%D97@U,2YH=&U02P$"% ,4    "  [@<)6D/>&PM8+  "2#   $0
M        @ $O^P  9S4Q-38Q,6<X.78X."YJ<&=02P4&      L "P"Q @
&- <!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
